A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines
Phase of Trial: Phase IV
Latest Information Update: 14 Sep 2015
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Allergan
- 15 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Apr 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2014 to 1 Jun 2014.
- 22 Apr 2014 According to the ClinicalTrials.gov record, status changed from completed to active, no longer recruiting.